These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 32376393)
1. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Raucci F; Mansour AA; Casillo GM; Saviano A; Caso F; Scarpa R; Mascolo N; Iqbal AJ; Maione F Autoimmun Rev; 2020 Jul; 19(7):102572. PubMed ID: 32376393 [No Abstract] [Full Text] [Related]
2. Diabetes and severity of COVID-19: What is the link? Pitocco D; Viti L; Tartaglione L; Di Leo M; Rizzo GE; Manto A; Rizzi A; Caputo S; Pontecorvi A Med Hypotheses; 2020 Oct; 143():109923. PubMed ID: 32485315 [TBL] [Abstract][Full Text] [Related]
3. Is a "Cytokine Storm" Relevant to COVID-19? Sinha P; Matthay MA; Calfee CS JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883 [No Abstract] [Full Text] [Related]
4. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports"). Persad G; Emanuel EJ JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357 [No Abstract] [Full Text] [Related]
6. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595 [TBL] [Abstract][Full Text] [Related]
7. Privileges and Immunity Certification During the COVID-19 Pandemic. Hall MA; Studdert DM JAMA; 2020 Jun; 323(22):2243-2244. PubMed ID: 32374358 [No Abstract] [Full Text] [Related]
8. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 associated viral myocarditis: does it exist? Verma V; Sondhi S; Sharma R; Mahajan K Monaldi Arch Chest Dis; 2020 Sep; 90(4):. PubMed ID: 32945641 [TBL] [Abstract][Full Text] [Related]
10. Will SARS-CoV-2 become endemic? Shaman J; Galanti M Science; 2020 Oct; 370(6516):527-529. PubMed ID: 33055131 [No Abstract] [Full Text] [Related]
12. Viral infections and atherothrombosis: Another caution in the wake of COVID-19? Pereira MP; Lima EG; Serrano Junior CV Rev Assoc Med Bras (1992); 2020 Mar; 66(3):366-369. PubMed ID: 32520159 [No Abstract] [Full Text] [Related]
13. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection. Meira E Cruz M; Miyazawa M; Gozal D Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32350105 [TBL] [Abstract][Full Text] [Related]
17. Signals of T Roncati L; Nasillo V; Lusenti B; Riva G Ann Hematol; 2020 Jun; 99(6):1419-1420. PubMed ID: 32382776 [No Abstract] [Full Text] [Related]
18. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response. Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV Front Immunol; 2020; 11():1748. PubMed ID: 32849623 [TBL] [Abstract][Full Text] [Related]
19. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm. Nowill AE; de Campos-Lima PO J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687 [TBL] [Abstract][Full Text] [Related]
20. Early Insights into Immune Responses during COVID-19. St John AL; Rathore APS J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]